AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tandem Diabetes Care has announced the availability of its t:slim X2 insulin pump with Abbott's FreeStyle Libre 3 Plus sensor integration in the US. This is the first step in a global commercial rollout, expanding choice and personalization for people living with diabetes worldwide. The integrated technologies will be available internationally through early-access programs before the end of the year, with commercial availability in 2026.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet